

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.32929310 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.32929310 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 6.97568042 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.97568042 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.83565593 |
| 6 | indole-containing compound catabolic process (GO:0042436) | 6.38421243 |
| 7 | indolalkylamine catabolic process (GO:0046218) | 6.38421243 |
| 8 | tryptophan catabolic process (GO:0006569) | 6.38421243 |
| 9 | tryptophan metabolic process (GO:0006568) | 6.11076910 |
| 10 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.09458563 |
| 11 | kynurenine metabolic process (GO:0070189) | 5.97805265 |
| 12 | bile acid biosynthetic process (GO:0006699) | 5.78491579 |
| 13 | glyoxylate metabolic process (GO:0046487) | 5.53559879 |
| 14 | high-density lipoprotein particle remodeling (GO:0034375) | 5.53397684 |
| 15 | urea cycle (GO:0000050) | 5.47569230 |
| 16 | urea metabolic process (GO:0019627) | 5.47569230 |
| 17 | alpha-linolenic acid metabolic process (GO:0036109) | 5.30765406 |
| 18 | sulfur amino acid catabolic process (GO:0000098) | 5.13110030 |
| 19 | protein carboxylation (GO:0018214) | 5.09432230 |
| 20 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.09432230 |
| 21 | negative regulation of fibrinolysis (GO:0051918) | 5.07413905 |
| 22 | nitrogen cycle metabolic process (GO:0071941) | 5.03425732 |
| 23 | aromatic amino acid family metabolic process (GO:0009072) | 5.03424469 |
| 24 | regulation of fibrinolysis (GO:0051917) | 5.01377068 |
| 25 | serine family amino acid catabolic process (GO:0009071) | 4.99562021 |
| 26 | bile acid metabolic process (GO:0008206) | 4.99282430 |
| 27 | regulation of cholesterol esterification (GO:0010872) | 4.98134105 |
| 28 | cysteine metabolic process (GO:0006534) | 4.94909331 |
| 29 | complement activation, alternative pathway (GO:0006957) | 4.91067899 |
| 30 | homocysteine metabolic process (GO:0050667) | 4.88636661 |
| 31 | tyrosine metabolic process (GO:0006570) | 4.88060763 |
| 32 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.86724187 |
| 33 | regulation of protein activation cascade (GO:2000257) | 4.86534902 |
| 34 | reverse cholesterol transport (GO:0043691) | 4.82923395 |
| 35 | plasma lipoprotein particle remodeling (GO:0034369) | 4.76077085 |
| 36 | protein-lipid complex remodeling (GO:0034368) | 4.76077085 |
| 37 | macromolecular complex remodeling (GO:0034367) | 4.76077085 |
| 38 | regulation of triglyceride catabolic process (GO:0010896) | 4.72449066 |
| 39 | amino-acid betaine metabolic process (GO:0006577) | 4.67081977 |
| 40 | indolalkylamine metabolic process (GO:0006586) | 4.63681674 |
| 41 | alpha-amino acid catabolic process (GO:1901606) | 4.61325022 |
| 42 | amine catabolic process (GO:0009310) | 4.58834188 |
| 43 | cellular biogenic amine catabolic process (GO:0042402) | 4.58834188 |
| 44 | phospholipid efflux (GO:0033700) | 4.58502476 |
| 45 | epoxygenase P450 pathway (GO:0019373) | 4.53306972 |
| 46 | triglyceride homeostasis (GO:0070328) | 4.53150947 |
| 47 | acylglycerol homeostasis (GO:0055090) | 4.53150947 |
| 48 | regulation of complement activation (GO:0030449) | 4.52606319 |
| 49 | cellular ketone body metabolic process (GO:0046950) | 4.41532699 |
| 50 | bile acid and bile salt transport (GO:0015721) | 4.40761212 |
| 51 | lysine catabolic process (GO:0006554) | 4.38352511 |
| 52 | lysine metabolic process (GO:0006553) | 4.38352511 |
| 53 | imidazole-containing compound metabolic process (GO:0052803) | 4.33315173 |
| 54 | negative regulation of cholesterol transport (GO:0032375) | 4.31491156 |
| 55 | negative regulation of sterol transport (GO:0032372) | 4.31491156 |
| 56 | coenzyme catabolic process (GO:0009109) | 4.29692334 |
| 57 | cellular glucuronidation (GO:0052695) | 4.28361794 |
| 58 | cellular amino acid catabolic process (GO:0009063) | 4.23740927 |
| 59 | cholesterol efflux (GO:0033344) | 4.21023631 |
| 60 | benzene-containing compound metabolic process (GO:0042537) | 4.19441838 |
| 61 | low-density lipoprotein particle remodeling (GO:0034374) | 4.14394310 |
| 62 | oxidative demethylation (GO:0070989) | 4.14084799 |
| 63 | S-adenosylmethionine metabolic process (GO:0046500) | 4.11223594 |
| 64 | glycine metabolic process (GO:0006544) | 4.09813695 |
| 65 | drug metabolic process (GO:0017144) | 4.05097833 |
| 66 | plasma lipoprotein particle clearance (GO:0034381) | 4.04455738 |
| 67 | drug catabolic process (GO:0042737) | 4.02937894 |
| 68 | aldehyde catabolic process (GO:0046185) | 4.02761923 |
| 69 | NAD biosynthetic process (GO:0009435) | 3.99046722 |
| 70 | arginine metabolic process (GO:0006525) | 3.98712143 |
| 71 | glutamate metabolic process (GO:0006536) | 3.97648286 |
| 72 | serine family amino acid metabolic process (GO:0009069) | 3.92501233 |
| 73 | plasma lipoprotein particle assembly (GO:0034377) | 3.89864909 |
| 74 | glucuronate metabolic process (GO:0019585) | 3.86633308 |
| 75 | uronic acid metabolic process (GO:0006063) | 3.86633308 |
| 76 | regulation of plasminogen activation (GO:0010755) | 3.83815902 |
| 77 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.81808966 |
| 78 | cellular modified amino acid catabolic process (GO:0042219) | 3.81671969 |
| 79 | arginine catabolic process (GO:0006527) | 3.81086929 |
| 80 | ketone body metabolic process (GO:1902224) | 3.80578864 |
| 81 | omega-hydroxylase P450 pathway (GO:0097267) | 3.79528764 |
| 82 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.78546120 |
| 83 | organic acid catabolic process (GO:0016054) | 3.78294109 |
| 84 | carboxylic acid catabolic process (GO:0046395) | 3.78294109 |
| 85 | negative regulation of lipase activity (GO:0060192) | 3.77902464 |
| 86 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.77518275 |
| 87 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.77518275 |
| 88 | regulation of bile acid biosynthetic process (GO:0070857) | 3.77220917 |
| 89 | cofactor catabolic process (GO:0051187) | 3.75836869 |
| 90 | blood coagulation, intrinsic pathway (GO:0007597) | 3.73225470 |
| 91 | ethanol oxidation (GO:0006069) | 3.71253074 |
| 92 | phospholipid homeostasis (GO:0055091) | 3.71050066 |
| 93 | serine family amino acid biosynthetic process (GO:0009070) | 3.68828235 |
| 94 | fibrinolysis (GO:0042730) | 3.66117099 |
| 95 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.64614235 |
| 96 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.64614235 |
| 97 | plasma lipoprotein particle organization (GO:0071827) | 3.63717544 |
| 98 | cholesterol homeostasis (GO:0042632) | 3.61261311 |
| 99 | positive regulation of lipid catabolic process (GO:0050996) | 3.58810530 |
| 100 | quinone biosynthetic process (GO:1901663) | 3.58281884 |
| 101 | short-chain fatty acid metabolic process (GO:0046459) | 3.58225987 |
| 102 | phenylpropanoid metabolic process (GO:0009698) | 3.58111419 |
| 103 | flavonoid metabolic process (GO:0009812) | 3.56797298 |
| 104 | exogenous drug catabolic process (GO:0042738) | 3.54722976 |
| 105 | sterol homeostasis (GO:0055092) | 3.54286909 |
| 106 | protein activation cascade (GO:0072376) | 3.51657390 |
| 107 | carnitine metabolic process (GO:0009437) | 3.48134349 |
| 108 | monocarboxylic acid catabolic process (GO:0072329) | 3.47953869 |
| 109 | complement activation, classical pathway (GO:0006958) | 3.45271888 |
| 110 | behavioral response to nicotine (GO:0035095) | 3.43443313 |
| 111 | L-methionine salvage (GO:0071267) | 3.36377192 |
| 112 | L-methionine biosynthetic process (GO:0071265) | 3.36377192 |
| 113 | amino acid salvage (GO:0043102) | 3.36377192 |
| 114 | ubiquinone biosynthetic process (GO:0006744) | 3.36348173 |
| 115 | L-serine metabolic process (GO:0006563) | 3.29393493 |
| 116 | quinone metabolic process (GO:1901661) | 3.29322454 |
| 117 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.29009043 |
| 118 | alkaloid metabolic process (GO:0009820) | 3.24911736 |
| 119 | intestinal cholesterol absorption (GO:0030299) | 3.22581779 |
| 120 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.18113708 |
| 121 | heme transport (GO:0015886) | 3.13784823 |
| 122 | response to misfolded protein (GO:0051788) | 3.11251172 |
| 123 | ubiquinone metabolic process (GO:0006743) | 3.05780113 |
| 124 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.05655439 |
| 125 | daunorubicin metabolic process (GO:0044597) | 2.97380400 |
| 126 | polyketide metabolic process (GO:0030638) | 2.97380400 |
| 127 | doxorubicin metabolic process (GO:0044598) | 2.97380400 |
| 128 | proline metabolic process (GO:0006560) | 2.97306441 |
| 129 | nucleobase catabolic process (GO:0046113) | 2.88493316 |
| 130 | peptidyl-glutamic acid modification (GO:0018200) | 2.82702507 |
| 131 | ethanol metabolic process (GO:0006067) | 2.81289849 |
| 132 | sulfur amino acid metabolic process (GO:0000096) | 2.80899596 |
| 133 | regulation of lipoprotein particle clearance (GO:0010984) | 2.79469879 |
| 134 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.79455858 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.01169376 |
| 2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.26380087 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.77552081 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.16191651 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.19985942 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.15001190 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.26589978 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.11954809 |
| 9 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.89630662 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.87187655 |
| 11 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.90950840 |
| 12 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.59869260 |
| 13 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.34208606 |
| 14 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.31702988 |
| 15 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.09499855 |
| 16 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.03305602 |
| 17 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.2727105 |
| 18 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.97547851 |
| 19 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.96396811 |
| 20 | P68_20966046_ChIP-Seq_HELA_Human | 1.93355381 |
| 21 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.88611625 |
| 22 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.85022998 |
| 23 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.82860269 |
| 24 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.80456367 |
| 25 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.79046220 |
| 26 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.76429081 |
| 27 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.75469188 |
| 28 | * ERA_21632823_ChIP-Seq_H3396_Human | 1.68063827 |
| 29 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.64821176 |
| 30 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.62102584 |
| 31 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.61937947 |
| 32 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.61002391 |
| 33 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.60509816 |
| 34 | GATA1_22025678_ChIP-Seq_K562_Human | 1.58967206 |
| 35 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.54476927 |
| 36 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.52404005 |
| 37 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.52007691 |
| 38 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.50549081 |
| 39 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.50288760 |
| 40 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.50103588 |
| 41 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.46295534 |
| 42 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.46155194 |
| 43 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.45918763 |
| 44 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.45182811 |
| 45 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.44024813 |
| 46 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.38400090 |
| 47 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.38321692 |
| 48 | SA1_27219007_Chip-Seq_Bcells_Human | 1.38066909 |
| 49 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.37677438 |
| 50 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.35711088 |
| 51 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.33196117 |
| 52 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.32094985 |
| 53 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.31240937 |
| 54 | P53_21459846_ChIP-Seq_SAOS-2_Human | 1.30696966 |
| 55 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.30246434 |
| 56 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.26457593 |
| 57 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.24068082 |
| 58 | P300_27268052_Chip-Seq_Bcells_Human | 1.22910374 |
| 59 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.20100604 |
| 60 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 1.19587692 |
| 61 | * CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.18882731 |
| 62 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.17522985 |
| 63 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.16614289 |
| 64 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.16511619 |
| 65 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.14691562 |
| 66 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.14130328 |
| 67 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.13499176 |
| 68 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.12468380 |
| 69 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.11730913 |
| 70 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.11362390 |
| 71 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.11061580 |
| 72 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.10527807 |
| 73 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.09936485 |
| 74 | * SOX2_21211035_ChIP-Seq_LN229_Human | 1.09274355 |
| 75 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.08961560 |
| 76 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.06464888 |
| 77 | NCOR_22424771_ChIP-Seq_293T_Human | 1.03895957 |
| 78 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.03226305 |
| 79 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.02912608 |
| 80 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.02866470 |
| 81 | VDR_22108803_ChIP-Seq_LS180_Human | 1.02703132 |
| 82 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.01888126 |
| 83 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.01762330 |
| 84 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.00809446 |
| 85 | LDB1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.99846297 |
| 86 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.99812366 |
| 87 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.99447556 |
| 88 | * SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.98975609 |
| 89 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.98073688 |
| 90 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.97637593 |
| 91 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.97373271 |
| 92 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.97239784 |
| 93 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.96707945 |
| 94 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.96649429 |
| 95 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.96405533 |
| 96 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.95724585 |
| 97 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.95380530 |
| 98 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.95211999 |
| 99 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.94398488 |
| 100 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.92091410 |
| 101 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.90835494 |
| 102 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.89330654 |
| 103 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.84646936 |
| 104 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.81978987 |
| 105 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.80579291 |
| 106 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.80081109 |
| 107 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.80081109 |
| 108 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.79710701 |
| 109 | AR_20517297_ChIP-Seq_VCAP_Human | 0.79705870 |
| 110 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.78770313 |
| 111 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.75691749 |
| 112 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.75387379 |
| 113 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.73219934 |
| 114 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.73009968 |
| 115 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.70016143 |
| 116 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.69323317 |
| 117 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.68597263 |
| 118 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.67848349 |
| 119 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.67368724 |
| 120 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.67102437 |
| 121 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.66028126 |
| 122 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.65109171 |
| 123 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.63975067 |
| 124 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.62504679 |
| 125 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.62409631 |
| 126 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.62363717 |
| 127 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.61035083 |
| 128 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.60881367 |
| 129 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.60727174 |
| 130 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.58732132 |
| 131 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.58590057 |
| 132 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.58402058 |
| 133 | * SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.58005202 |
| 134 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.57408480 |
| 135 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.57389510 |
| 136 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.57384157 |
| 137 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.56773469 |
| 138 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.56691354 |
| 139 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.56637332 |
| 140 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.55420237 |
| 141 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.55184332 |
| 142 | CBP_21632823_ChIP-Seq_H3396_Human | 0.54498286 |
| 143 | * PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.54341997 |
| 144 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.53946199 |
| 145 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.53450283 |
| 146 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.52843111 |
| 147 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.52679163 |
| 148 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.52533552 |
| 149 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.52316762 |
| 150 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.52231785 |
| 151 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.52018405 |
| 152 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.51997148 |
| 153 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.51845591 |
| 154 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.51731841 |
| 155 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.51457947 |
| 156 | * MYC_19915707_ChIP-ChIP_AK7_Human | 0.51041045 |
| 157 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.50503631 |
| 158 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.50192592 |
| 159 | * ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.49804277 |
| 160 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.49053980 |
| 161 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.48967785 |
| 162 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.48193303 |
| 163 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.47082035 |
| 164 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.47018267 |
| 165 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.46970340 |
| 166 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.46824382 |
| 167 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.46819482 |
| 168 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.45037860 |
| 169 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.44999765 |
| 170 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.44975732 |
| 171 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.44553232 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.20870137 |
| 2 | MP0005360_urolithiasis | 7.23630101 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.44978536 |
| 4 | MP0005365_abnormal_bile_salt | 6.29795995 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.24901421 |
| 6 | MP0003252_abnormal_bile_duct | 3.91785075 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 3.91369943 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.54013604 |
| 9 | MP0003195_calcinosis | 2.93354551 |
| 10 | MP0009840_abnormal_foam_cell | 2.88954180 |
| 11 | MP0005083_abnormal_biliary_tract | 2.87355961 |
| 12 | MP0005332_abnormal_amino_acid | 2.84395823 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.58934837 |
| 14 | MP0004019_abnormal_vitamin_homeostasis | 2.36222499 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.20189648 |
| 16 | MP0002138_abnormal_hepatobiliary_system | 2.16705669 |
| 17 | MP0009697_abnormal_copulation | 2.13393936 |
| 18 | MP0000609_abnormal_liver_physiology | 2.07536395 |
| 19 | MP0002118_abnormal_lipid_homeostasis | 2.05224937 |
| 20 | MP0001986_abnormal_taste_sensitivity | 2.02301852 |
| 21 | MP0003868_abnormal_feces_composition | 2.01961700 |
| 22 | MP0001764_abnormal_homeostasis | 1.92998732 |
| 23 | MP0005319_abnormal_enzyme/_coenzyme | 1.80499295 |
| 24 | MP0005451_abnormal_body_composition | 1.71544559 |
| 25 | MP0004147_increased_porphyrin_level | 1.62564510 |
| 26 | MP0006292_abnormal_olfactory_placode | 1.61304112 |
| 27 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.53606660 |
| 28 | MP0003646_muscle_fatigue | 1.53444401 |
| 29 | MP0002876_abnormal_thyroid_physiology | 1.51179782 |
| 30 | MP0003011_delayed_dark_adaptation | 1.50975473 |
| 31 | MP0004133_heterotaxia | 1.50264843 |
| 32 | MP0003186_abnormal_redox_activity | 1.49866440 |
| 33 | MP0001968_abnormal_touch/_nociception | 1.47073151 |
| 34 | MP0000013_abnormal_adipose_tissue | 1.32873607 |
| 35 | MP0005551_abnormal_eye_electrophysiolog | 1.31800013 |
| 36 | MP0002653_abnormal_ependyma_morphology | 1.29519827 |
| 37 | MP0009643_abnormal_urine_homeostasis | 1.27827416 |
| 38 | MP0009764_decreased_sensitivity_to | 1.27538899 |
| 39 | MP0003879_abnormal_hair_cell | 1.24678838 |
| 40 | MP0005647_abnormal_sex_gland | 1.22444403 |
| 41 | MP0002736_abnormal_nociception_after | 1.15417223 |
| 42 | MP0000598_abnormal_liver_morphology | 1.10562443 |
| 43 | MP0006276_abnormal_autonomic_nervous | 1.09340706 |
| 44 | MP0005670_abnormal_white_adipose | 1.08719005 |
| 45 | MP0008789_abnormal_olfactory_epithelium | 1.06336173 |
| 46 | MP0008995_early_reproductive_senescence | 1.05760387 |
| 47 | MP0003122_maternal_imprinting | 1.05225327 |
| 48 | MP0005084_abnormal_gallbladder_morpholo | 1.04876733 |
| 49 | MP0003656_abnormal_erythrocyte_physiolo | 1.03692732 |
| 50 | MP0000003_abnormal_adipose_tissue | 1.02318288 |
| 51 | MP0001529_abnormal_vocalization | 1.00408368 |
| 52 | MP0009763_increased_sensitivity_to | 0.99848571 |
| 53 | MP0005636_abnormal_mineral_homeostasis | 0.99478874 |
| 54 | MP0002254_reproductive_system_inflammat | 0.99380890 |
| 55 | MP0002160_abnormal_reproductive_system | 0.97365628 |
| 56 | MP0008469_abnormal_protein_level | 0.95430961 |
| 57 | MP0009384_cardiac_valve_regurgitation | 0.93945264 |
| 58 | MP0005408_hypopigmentation | 0.91473847 |
| 59 | MP0009642_abnormal_blood_homeostasis | 0.90643662 |
| 60 | MP0002938_white_spotting | 0.90622159 |
| 61 | MP0002234_abnormal_pharynx_morphology | 0.89547461 |
| 62 | MP0008775_abnormal_heart_ventricle | 0.89288250 |
| 63 | MP0006036_abnormal_mitochondrial_physio | 0.85678186 |
| 64 | MP0002249_abnormal_larynx_morphology | 0.85293352 |
| 65 | MP0009765_abnormal_xenobiotic_induced | 0.84228290 |
| 66 | MP0004142_abnormal_muscle_tone | 0.83019857 |
| 67 | MP0002102_abnormal_ear_morphology | 0.82478265 |
| 68 | MP0002078_abnormal_glucose_homeostasis | 0.81744254 |
| 69 | MP0001502_abnormal_circadian_rhythm | 0.81332974 |
| 70 | MP0005376_homeostasis/metabolism_phenot | 0.80634131 |
| 71 | MP0005220_abnormal_exocrine_pancreas | 0.79898672 |
| 72 | MP0002638_abnormal_pupillary_reflex | 0.79728271 |
| 73 | MP0005058_abnormal_lysosome_morphology | 0.79685140 |
| 74 | MP0001905_abnormal_dopamine_level | 0.79546819 |
| 75 | MP0002735_abnormal_chemical_nociception | 0.77241463 |
| 76 | MP0005389_reproductive_system_phenotype | 0.75808633 |
| 77 | MP0000049_abnormal_middle_ear | 0.75232575 |
| 78 | MP0005535_abnormal_body_temperature | 0.74546505 |
| 79 | MP0008877_abnormal_DNA_methylation | 0.74490044 |
| 80 | MP0000678_abnormal_parathyroid_gland | 0.74208977 |
| 81 | MP0004145_abnormal_muscle_electrophysio | 0.73427184 |
| 82 | MP0003724_increased_susceptibility_to | 0.73225094 |
| 83 | MP0001756_abnormal_urination | 0.72925423 |
| 84 | MP0005334_abnormal_fat_pad | 0.72590495 |
| 85 | MP0005394_taste/olfaction_phenotype | 0.72297639 |
| 86 | MP0005499_abnormal_olfactory_system | 0.72297639 |
| 87 | MP0005410_abnormal_fertilization | 0.71705383 |
| 88 | MP0000604_amyloidosis | 0.71575707 |
| 89 | MP0004782_abnormal_surfactant_physiolog | 0.71055680 |
| 90 | MP0002557_abnormal_social/conspecific_i | 0.68749553 |
| 91 | MP0001661_extended_life_span | 0.68234072 |
| 92 | MP0009745_abnormal_behavioral_response | 0.66029449 |
| 93 | MP0005266_abnormal_metabolism | 0.62835908 |
| 94 | MP0003878_abnormal_ear_physiology | 0.62217886 |
| 95 | MP0005377_hearing/vestibular/ear_phenot | 0.62217886 |
| 96 | MP0003698_abnormal_male_reproductive | 0.61803641 |
| 97 | MP0002733_abnormal_thermal_nociception | 0.61688829 |
| 98 | MP0002971_abnormal_brown_adipose | 0.61587756 |
| 99 | MP0000372_irregular_coat_pigmentation | 0.59951250 |
| 100 | MP0010368_abnormal_lymphatic_system | 0.59637254 |
| 101 | MP0002282_abnormal_trachea_morphology | 0.59413232 |
| 102 | MP0006035_abnormal_mitochondrial_morpho | 0.59033233 |
| 103 | MP0003137_abnormal_impulse_conducting | 0.58389583 |
| 104 | MP0003938_abnormal_ear_development | 0.58347141 |
| 105 | MP0005645_abnormal_hypothalamus_physiol | 0.57547641 |
| 106 | MP0005448_abnormal_energy_balance | 0.57515787 |
| 107 | MP0003718_maternal_effect | 0.57295139 |
| 108 | MP0000639_abnormal_adrenal_gland | 0.56804355 |
| 109 | MP0000026_abnormal_inner_ear | 0.56627532 |
| 110 | MP0005464_abnormal_platelet_physiology | 0.55250896 |
| 111 | MP0002132_abnormal_respiratory_system | 0.54839205 |
| 112 | MP0004381_abnormal_hair_follicle | 0.54069087 |
| 113 | MP0005395_other_phenotype | 0.50993821 |
| 114 | MP0002928_abnormal_bile_duct | 0.50829487 |
| 115 | MP0002136_abnormal_kidney_physiology | 0.50296660 |
| 116 | MP0004130_abnormal_muscle_cell | 0.49664665 |
| 117 | MP0003953_abnormal_hormone_level | 0.48693460 |
| 118 | MP0003638_abnormal_response/metabolism_ | 0.47418827 |
| 119 | MP0003436_decreased_susceptibility_to | 0.47096780 |
| 120 | MP0008872_abnormal_physiological_respon | 0.46414470 |
| 121 | MP0005248_abnormal_Harderian_gland | 0.45418236 |
| 122 | MP0002822_catalepsy | 0.44844751 |
| 123 | MP0000230_abnormal_systemic_arterial | 0.42562345 |
| 124 | MP0001853_heart_inflammation | 0.41834633 |
| 125 | MP0009053_abnormal_anal_canal | 0.41428987 |
| 126 | MP0003690_abnormal_glial_cell | 0.41189562 |
| 127 | MP0005646_abnormal_pituitary_gland | 0.40132419 |
| 128 | MP0005075_abnormal_melanosome_morpholog | 0.38884757 |
| 129 | MP0008874_decreased_physiological_sensi | 0.37288071 |
| 130 | MP0004264_abnormal_extraembryonic_tissu | 0.37046003 |
| 131 | MP0009785_altered_susceptibility_to | 0.36954005 |
| 132 | MP0001845_abnormal_inflammatory_respons | 0.36820839 |
| 133 | MP0000566_synostosis | 0.36480513 |
| 134 | MP0003705_abnormal_hypodermis_morpholog | 0.35535806 |
| 135 | MP0008873_increased_physiological_sensi | 0.34433511 |
| 136 | MP0002837_dystrophic_cardiac_calcinosis | 0.34096999 |
| 137 | MP0000579_abnormal_nail_morphology | 0.33812007 |
| 138 | MP0009115_abnormal_fat_cell | 0.32822576 |
| 139 | MP0000538_abnormal_urinary_bladder | 0.31281017 |
| 140 | MP0005166_decreased_susceptibility_to | 0.30985135 |
| 141 | MP0002168_other_aberrant_phenotype | 0.30838044 |
| 142 | MP0006082_CNS_inflammation | 0.30778115 |
| 143 | MP0001881_abnormal_mammary_gland | 0.30626675 |
| 144 | MP0000427_abnormal_hair_cycle | 0.28342621 |
| 145 | MP0005379_endocrine/exocrine_gland_phen | 0.28119401 |
| 146 | MP0001324_abnormal_eye_pigmentation | 0.27599433 |
| 147 | MP0004883_abnormal_blood_vessel | 0.26758070 |
| 148 | MP0003075_altered_response_to | 0.26734439 |
| 149 | MP0005666_abnormal_adipose_tissue | 0.26002218 |
| 150 | MP0004043_abnormal_pH_regulation | 0.25881338 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.19741073 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 7.01261929 |
| 3 | Prolonged partial thromboplastin time (HP:0003645) | 6.61326454 |
| 4 | Deep venous thrombosis (HP:0002625) | 6.51465952 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.50265526 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.11058320 |
| 7 | Xanthomatosis (HP:0000991) | 5.81935663 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.28902900 |
| 9 | Joint hemorrhage (HP:0005261) | 4.89379397 |
| 10 | Complement deficiency (HP:0004431) | 4.69583016 |
| 11 | Hypolipoproteinemia (HP:0010981) | 4.57939740 |
| 12 | Hyperammonemia (HP:0001987) | 4.48303432 |
| 13 | Abnormality of methionine metabolism (HP:0010901) | 4.39762281 |
| 14 | Hyperglycinemia (HP:0002154) | 4.38015731 |
| 15 | Epidermoid cyst (HP:0200040) | 4.31330645 |
| 16 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.22768725 |
| 17 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.20741487 |
| 18 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.19990010 |
| 19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.16385701 |
| 20 | Ketosis (HP:0001946) | 4.14164350 |
| 21 | Hyperglycinuria (HP:0003108) | 4.13949832 |
| 22 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.13262140 |
| 23 | Conjugated hyperbilirubinemia (HP:0002908) | 4.13005858 |
| 24 | Abnormality of the common coagulation pathway (HP:0010990) | 4.11781721 |
| 25 | Fat malabsorption (HP:0002630) | 4.09842363 |
| 26 | Hypoalphalipoproteinemia (HP:0003233) | 4.02674736 |
| 27 | Hypoglycemic coma (HP:0001325) | 3.92771381 |
| 28 | Abnormality of glycine metabolism (HP:0010895) | 3.88203851 |
| 29 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.88203851 |
| 30 | Abnormality of the intrinsic pathway (HP:0010989) | 3.75901670 |
| 31 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.57591715 |
| 32 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.51030156 |
| 33 | Hypercholesterolemia (HP:0003124) | 3.43536632 |
| 34 | Abnormality of complement system (HP:0005339) | 3.42141858 |
| 35 | Hyperbilirubinemia (HP:0002904) | 3.37100975 |
| 36 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.34835436 |
| 37 | Abnormality of alanine metabolism (HP:0010916) | 3.34835436 |
| 38 | Hyperalaninemia (HP:0003348) | 3.34835436 |
| 39 | Abnormality of serum amino acid levels (HP:0003112) | 3.22461577 |
| 40 | Abnormality of nucleobase metabolism (HP:0010932) | 3.22109909 |
| 41 | Steatorrhea (HP:0002570) | 3.12599023 |
| 42 | Cerebral palsy (HP:0100021) | 3.06510299 |
| 43 | Acute encephalopathy (HP:0006846) | 3.05672357 |
| 44 | Delayed CNS myelination (HP:0002188) | 3.04284658 |
| 45 | Ketoacidosis (HP:0001993) | 2.98868413 |
| 46 | Hepatic necrosis (HP:0002605) | 2.96375939 |
| 47 | Metabolic acidosis (HP:0001942) | 2.93250238 |
| 48 | Hepatocellular necrosis (HP:0001404) | 2.89024788 |
| 49 | Spontaneous abortion (HP:0005268) | 2.83637338 |
| 50 | Lethargy (HP:0001254) | 2.81964445 |
| 51 | Dicarboxylic aciduria (HP:0003215) | 2.76937088 |
| 52 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.76937088 |
| 53 | Hepatocellular carcinoma (HP:0001402) | 2.76915787 |
| 54 | Abnormality of purine metabolism (HP:0004352) | 2.76533793 |
| 55 | Hypoglycemic seizures (HP:0002173) | 2.72151268 |
| 56 | Mitochondrial inheritance (HP:0001427) | 2.71191548 |
| 57 | Systemic lupus erythematosus (HP:0002725) | 2.66500219 |
| 58 | Hypochromic microcytic anemia (HP:0004840) | 2.66148015 |
| 59 | Myocardial infarction (HP:0001658) | 2.65293333 |
| 60 | Cerebral edema (HP:0002181) | 2.64554019 |
| 61 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.61278592 |
| 62 | Acute necrotizing encephalopathy (HP:0006965) | 2.60618955 |
| 63 | Renal cortical cysts (HP:0000803) | 2.58063024 |
| 64 | Generalized aminoaciduria (HP:0002909) | 2.56463399 |
| 65 | Skin nodule (HP:0200036) | 2.56282406 |
| 66 | Increased CSF lactate (HP:0002490) | 2.56099091 |
| 67 | Vascular calcification (HP:0004934) | 2.55767135 |
| 68 | Mesangial abnormality (HP:0001966) | 2.50075990 |
| 69 | Gout (HP:0001997) | 2.45159183 |
| 70 | Increased serum lactate (HP:0002151) | 2.43573000 |
| 71 | Retinal atrophy (HP:0001105) | 2.41659897 |
| 72 | Methylmalonic aciduria (HP:0012120) | 2.40735443 |
| 73 | Lactic acidosis (HP:0003128) | 2.40349790 |
| 74 | Acanthocytosis (HP:0001927) | 2.40132573 |
| 75 | Glomerulonephritis (HP:0000099) | 2.32711106 |
| 76 | Enlarged kidneys (HP:0000105) | 2.31834149 |
| 77 | Irritability (HP:0000737) | 2.27169133 |
| 78 | Type II lissencephaly (HP:0007260) | 2.26733853 |
| 79 | Pancreatitis (HP:0001733) | 2.25794666 |
| 80 | Increased muscle lipid content (HP:0009058) | 2.24962878 |
| 81 | Brushfield spots (HP:0001088) | 2.24439184 |
| 82 | Mitral stenosis (HP:0001718) | 2.23933100 |
| 83 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.23362842 |
| 84 | Reduced antithrombin III activity (HP:0001976) | 2.22921738 |
| 85 | Cardiovascular calcification (HP:0011915) | 2.22135767 |
| 86 | Abnormal gallbladder morphology (HP:0012437) | 2.21557494 |
| 87 | Menorrhagia (HP:0000132) | 2.21541149 |
| 88 | Gingival bleeding (HP:0000225) | 2.21105481 |
| 89 | Increased serum pyruvate (HP:0003542) | 2.20979510 |
| 90 | Opisthotonus (HP:0002179) | 2.19831894 |
| 91 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.19225752 |
| 92 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.16536262 |
| 93 | Lipid accumulation in hepatocytes (HP:0006561) | 2.16517964 |
| 94 | Proximal tubulopathy (HP:0000114) | 2.16478212 |
| 95 | Severe muscular hypotonia (HP:0006829) | 2.16299956 |
| 96 | Hyperphosphaturia (HP:0003109) | 2.15427132 |
| 97 | Vomiting (HP:0002013) | 2.15073845 |
| 98 | Sensorimotor neuropathy (HP:0007141) | 2.13417440 |
| 99 | Molar tooth sign on MRI (HP:0002419) | 2.12550292 |
| 100 | Abnormality of midbrain morphology (HP:0002418) | 2.12550292 |
| 101 | Rib fusion (HP:0000902) | 2.10933982 |
| 102 | Cholelithiasis (HP:0001081) | 2.09357595 |
| 103 | Alkalosis (HP:0001948) | 2.05954564 |
| 104 | Neonatal onset (HP:0003623) | 2.05916976 |
| 105 | Amyloidosis (HP:0011034) | 2.05803890 |
| 106 | Spastic diplegia (HP:0001264) | 2.05614627 |
| 107 | Malnutrition (HP:0004395) | 2.05172510 |
| 108 | Retinal dysplasia (HP:0007973) | 2.04995496 |
| 109 | Renal Fanconi syndrome (HP:0001994) | 2.02834976 |
| 110 | Increased intramyocellular lipid droplets (HP:0012240) | 2.00768581 |
| 111 | Hydroxyprolinuria (HP:0003080) | 2.00543196 |
| 112 | Abnormality of proline metabolism (HP:0010907) | 2.00543196 |
| 113 | Glycosuria (HP:0003076) | 2.00163790 |
| 114 | Abnormality of urine glucose concentration (HP:0011016) | 2.00163790 |
| 115 | Elevated hepatic transaminases (HP:0002910) | 1.98784421 |
| 116 | Esophageal varix (HP:0002040) | 1.97906393 |
| 117 | Type I transferrin isoform profile (HP:0003642) | 1.97760107 |
| 118 | Symptomatic seizures (HP:0011145) | 1.96030497 |
| 119 | Fair hair (HP:0002286) | 1.94903418 |
| 120 | Abnormal urine phosphate concentration (HP:0012599) | 1.94735429 |
| 121 | Pendular nystagmus (HP:0012043) | 1.94659211 |
| 122 | Abnormal gallbladder physiology (HP:0012438) | 1.93436607 |
| 123 | Cholecystitis (HP:0001082) | 1.93436607 |
| 124 | Abnormal protein glycosylation (HP:0012346) | 1.92773498 |
| 125 | Abnormal glycosylation (HP:0012345) | 1.92773498 |
| 126 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.92773498 |
| 127 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.92773498 |
| 128 | Thrombophlebitis (HP:0004418) | 1.92364906 |
| 129 | Rickets (HP:0002748) | 1.92184094 |
| 130 | Late onset (HP:0003584) | 1.90880183 |
| 131 | Congenital stationary night blindness (HP:0007642) | 1.90223621 |
| 132 | Abnormality of glycolysis (HP:0004366) | 1.89252604 |
| 133 | Hyperglycemia (HP:0003074) | 1.88059097 |
| 134 | Poikilocytosis (HP:0004447) | 1.87936053 |
| 135 | Progressive microcephaly (HP:0000253) | 1.84590818 |
| 136 | Progressive macrocephaly (HP:0004481) | 1.83363634 |
| 137 | Abnormality of vitamin metabolism (HP:0100508) | 1.83058643 |
| 138 | Acute hepatic failure (HP:0006554) | 1.82858331 |
| 139 | Abnormality of the gallbladder (HP:0005264) | 1.82678077 |
| 140 | Nephronophthisis (HP:0000090) | 1.82395542 |
| 141 | Hemorrhage of the eye (HP:0011885) | 1.80723273 |
| 142 | CNS demyelination (HP:0007305) | 1.80261715 |
| 143 | Hypophosphatemic rickets (HP:0004912) | 1.80076015 |
| 144 | Methylmalonic acidemia (HP:0002912) | 1.79729242 |
| 145 | Increased hepatocellular lipid droplets (HP:0006565) | 1.77812334 |
| 146 | Testicular atrophy (HP:0000029) | 1.77776112 |
| 147 | Pancreatic cysts (HP:0001737) | 1.77105432 |
| 148 | Tachypnea (HP:0002789) | 1.76664900 |
| 149 | Patellar aplasia (HP:0006443) | 1.75491236 |
| 150 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.74284395 |
| 151 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.74284395 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.39571677 |
| 2 | INSRR | 3.74307603 |
| 3 | FGFR4 | 3.45436524 |
| 4 | SIK1 | 3.45038456 |
| 5 | WNK4 | 3.32183321 |
| 6 | MAP4K2 | 3.15622536 |
| 7 | TAOK3 | 2.77648803 |
| 8 | TLK1 | 2.76933197 |
| 9 | ERN1 | 2.71912761 |
| 10 | IRAK3 | 2.59388773 |
| 11 | FRK | 2.47275447 |
| 12 | ERBB4 | 2.35813610 |
| 13 | MAPKAPK3 | 2.33440900 |
| 14 | FLT3 | 2.25838586 |
| 15 | MAP3K14 | 2.13400594 |
| 16 | MAP2K4 | 2.11962740 |
| 17 | STK38L | 2.02617189 |
| 18 | AKT3 | 1.99752534 |
| 19 | PHKG2 | 1.99744338 |
| 20 | PHKG1 | 1.99744338 |
| 21 | VRK2 | 1.93934183 |
| 22 | PIK3CG | 1.89177878 |
| 23 | PINK1 | 1.85109626 |
| 24 | CASK | 1.84405729 |
| 25 | NME1 | 1.80843828 |
| 26 | PDK2 | 1.77301611 |
| 27 | DYRK2 | 1.74927879 |
| 28 | MUSK | 1.71005316 |
| 29 | NEK9 | 1.68590875 |
| 30 | TYK2 | 1.66450799 |
| 31 | WNK3 | 1.62083336 |
| 32 | MST1R | 1.55960716 |
| 33 | MAPK11 | 1.52225805 |
| 34 | MAP2K2 | 1.49241316 |
| 35 | PIM2 | 1.47746327 |
| 36 | MAPK13 | 1.40233025 |
| 37 | SGK2 | 1.36001774 |
| 38 | STK16 | 1.35691775 |
| 39 | CSNK1G3 | 1.31181326 |
| 40 | TESK2 | 1.30882688 |
| 41 | MAP3K11 | 1.29034817 |
| 42 | PRKCI | 1.23996654 |
| 43 | MAP2K7 | 1.23332295 |
| 44 | ABL2 | 1.20587675 |
| 45 | DAPK2 | 1.19608046 |
| 46 | LIMK1 | 1.19069661 |
| 47 | MAP3K4 | 1.17244783 |
| 48 | JAK1 | 1.16042781 |
| 49 | TBK1 | 1.15120595 |
| 50 | OXSR1 | 1.15040694 |
| 51 | EPHA3 | 1.14516335 |
| 52 | STK39 | 1.13071729 |
| 53 | IKBKE | 1.08703256 |
| 54 | IRAK1 | 1.08244956 |
| 55 | ZAK | 1.08032311 |
| 56 | PRKAA2 | 1.06087955 |
| 57 | IRAK4 | 1.03237424 |
| 58 | MAP2K6 | 1.02759176 |
| 59 | PRKD3 | 1.02100403 |
| 60 | TIE1 | 1.01991875 |
| 61 | CCNB1 | 1.01871896 |
| 62 | ADRBK2 | 1.01530714 |
| 63 | TESK1 | 1.00647731 |
| 64 | SIK2 | 0.98742566 |
| 65 | MARK1 | 0.98432299 |
| 66 | EPHB2 | 0.98342792 |
| 67 | SIK3 | 0.97871354 |
| 68 | BMPR1B | 0.96964952 |
| 69 | CSNK1G1 | 0.96357801 |
| 70 | CSNK1A1L | 0.95915177 |
| 71 | SGK3 | 0.95103800 |
| 72 | NME2 | 0.95084065 |
| 73 | KDR | 0.94414560 |
| 74 | LATS1 | 0.94392838 |
| 75 | JAK2 | 0.94026751 |
| 76 | GRK1 | 0.86401651 |
| 77 | MET | 0.83611987 |
| 78 | TAOK2 | 0.83369368 |
| 79 | NLK | 0.80965620 |
| 80 | EIF2AK2 | 0.80743605 |
| 81 | PRKCZ | 0.79959513 |
| 82 | MAPK7 | 0.79638147 |
| 83 | MAPK4 | 0.79238369 |
| 84 | IRAK2 | 0.78017486 |
| 85 | NUAK1 | 0.76668425 |
| 86 | BMPR2 | 0.76277803 |
| 87 | ADRBK1 | 0.75812112 |
| 88 | CSNK1G2 | 0.75486089 |
| 89 | TXK | 0.74915306 |
| 90 | AURKA | 0.72712464 |
| 91 | CSNK1A1 | 0.72523250 |
| 92 | MAPK15 | 0.70600901 |
| 93 | MYLK | 0.69652144 |
| 94 | OBSCN | 0.69117592 |
| 95 | MAP3K7 | 0.68413005 |
| 96 | PRKD2 | 0.67659673 |
| 97 | SGK494 | 0.66941000 |
| 98 | SGK223 | 0.66941000 |
| 99 | PAK3 | 0.66046390 |
| 100 | CAMK2G | 0.65171653 |
| 101 | TRIB3 | 0.64820477 |
| 102 | MAP2K3 | 0.64616421 |
| 103 | RPS6KB2 | 0.64304292 |
| 104 | KIT | 0.64157382 |
| 105 | RPS6KA5 | 0.63962524 |
| 106 | PRKACG | 0.62755730 |
| 107 | IKBKB | 0.60680711 |
| 108 | PKN2 | 0.60661104 |
| 109 | TEC | 0.59878848 |
| 110 | PTK6 | 0.59518173 |
| 111 | PRKACA | 0.58894966 |
| 112 | FGFR3 | 0.57927713 |
| 113 | MAPK12 | 0.57706072 |
| 114 | PRKAA1 | 0.57575721 |
| 115 | PRKCG | 0.57473556 |
| 116 | TGFBR2 | 0.57038947 |
| 117 | PRKCE | 0.55707365 |
| 118 | MAP3K5 | 0.53462670 |
| 119 | MAPKAPK5 | 0.52957908 |
| 120 | RPS6KA2 | 0.52673687 |
| 121 | ERBB2 | 0.52670796 |
| 122 | CDK19 | 0.51583217 |
| 123 | RPS6KA6 | 0.51355213 |
| 124 | DYRK1B | 0.50886381 |
| 125 | MAP3K3 | 0.50660696 |
| 126 | VRK1 | 0.50109354 |
| 127 | PIK3CA | 0.48418777 |
| 128 | CHUK | 0.48216637 |
| 129 | EPHA2 | 0.48002227 |
| 130 | CAMK2D | 0.47498805 |
| 131 | PBK | 0.47045221 |
| 132 | FGFR2 | 0.46119999 |
| 133 | MAP3K6 | 0.45502989 |
| 134 | CDK8 | 0.45313675 |
| 135 | MAP2K1 | 0.44690912 |
| 136 | TNIK | 0.44582653 |
| 137 | ATR | 0.44534948 |
| 138 | CSNK2A1 | 0.43607384 |
| 139 | IGF1R | 0.43584511 |
| 140 | PRKCQ | 0.43569721 |
| 141 | ACVR1B | 0.41851897 |
| 142 | AKT2 | 0.41748719 |
| 143 | GRK7 | 0.40457814 |
| 144 | PAK6 | 0.39769878 |
| 145 | EPHA4 | 0.38309774 |
| 146 | CSK | 0.37051553 |
| 147 | JAK3 | 0.36484929 |
| 148 | PLK1 | 0.35763690 |
| 149 | CAMK1 | 0.35295747 |
| 150 | TNK2 | 0.35002434 |
| 151 | GRK6 | 0.34977556 |
| 152 | NEK2 | 0.34911953 |
| 153 | LYN | 0.34784159 |
| 154 | CSF1R | 0.34143694 |
| 155 | EIF2AK3 | 0.32987801 |
| 156 | RPS6KB1 | 0.32818678 |
| 157 | GSK3A | 0.32608619 |
| 158 | PRKCA | 0.31589523 |
| 159 | BLK | 0.31563667 |
| 160 | STK24 | 0.31527140 |
| 161 | CAMK4 | 0.30988037 |
| 162 | DAPK1 | 0.28433317 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.39235786 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.33466024 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.21806365 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.00769736 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.89750219 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.76235034 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.74857630 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.57256993 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.52212522 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.51989952 |
| 11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.45478076 |
| 12 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.41628248 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.38437836 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.19613487 |
| 15 | * Peroxisome_Homo sapiens_hsa04146 | 2.16976370 |
| 16 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.12850653 |
| 17 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.06340860 |
| 18 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.99674576 |
| 19 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.99655161 |
| 20 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.99601111 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.95763130 |
| 22 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.90142067 |
| 23 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.88038793 |
| 24 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.86743732 |
| 25 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.84579271 |
| 26 | Retinol metabolism_Homo sapiens_hsa00830 | 1.84154799 |
| 27 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.83242980 |
| 28 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.75292184 |
| 29 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.65777786 |
| 30 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.65183033 |
| 31 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.63530547 |
| 32 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.61364925 |
| 33 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.61121346 |
| 34 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.58704786 |
| 35 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.51257040 |
| 36 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.45411873 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.44488599 |
| 38 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.44018234 |
| 39 | Bile secretion_Homo sapiens_hsa04976 | 1.38602419 |
| 40 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.37209353 |
| 41 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.36127555 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.34651303 |
| 43 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.32030966 |
| 44 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.32025519 |
| 45 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.26514313 |
| 46 | ABC transporters_Homo sapiens_hsa02010 | 1.25416168 |
| 47 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.22664284 |
| 48 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.17709256 |
| 49 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.13594189 |
| 50 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.10900837 |
| 51 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.09296027 |
| 52 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.08065704 |
| 53 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.06782006 |
| 54 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.06139102 |
| 55 | Carbon metabolism_Homo sapiens_hsa01200 | 1.05663729 |
| 56 | Parkinsons disease_Homo sapiens_hsa05012 | 1.02047640 |
| 57 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.01496662 |
| 58 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.98972813 |
| 59 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.90567213 |
| 60 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.86295530 |
| 61 | Sulfur relay system_Homo sapiens_hsa04122 | 0.84157458 |
| 62 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.77144864 |
| 63 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.76273255 |
| 64 | Lysine degradation_Homo sapiens_hsa00310 | 0.73770913 |
| 65 | RNA polymerase_Homo sapiens_hsa03020 | 0.69955226 |
| 66 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.67686733 |
| 67 | Base excision repair_Homo sapiens_hsa03410 | 0.67607804 |
| 68 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.64498473 |
| 69 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.63171444 |
| 70 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.62572672 |
| 71 | Phototransduction_Homo sapiens_hsa04744 | 0.60553113 |
| 72 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.57874398 |
| 73 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.56617128 |
| 74 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.55173907 |
| 75 | Metabolic pathways_Homo sapiens_hsa01100 | 0.54253398 |
| 76 | Huntingtons disease_Homo sapiens_hsa05016 | 0.53208966 |
| 77 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.52288019 |
| 78 | Homologous recombination_Homo sapiens_hsa03440 | 0.45271316 |
| 79 | Alzheimers disease_Homo sapiens_hsa05010 | 0.44820368 |
| 80 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.43936596 |
| 81 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.43638917 |
| 82 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.42775921 |
| 83 | Other glycan degradation_Homo sapiens_hsa00511 | 0.42695355 |
| 84 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.38321782 |
| 85 | Galactose metabolism_Homo sapiens_hsa00052 | 0.35533119 |
| 86 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.34667286 |
| 87 | Proteasome_Homo sapiens_hsa03050 | 0.28511150 |
| 88 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.28297464 |
| 89 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.26584590 |
| 90 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.26426326 |
| 91 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.25201728 |
| 92 | Purine metabolism_Homo sapiens_hsa00230 | 0.24926708 |
| 93 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.23460841 |
| 94 | Prion diseases_Homo sapiens_hsa05020 | 0.20910280 |
| 95 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.17013158 |
| 96 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.13800384 |
| 97 | Insulin resistance_Homo sapiens_hsa04931 | 0.11980360 |
| 98 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.11263289 |
| 99 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.07975994 |
| 100 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.04343671 |
| 101 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.03365776 |
| 102 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.00314722 |
| 103 | Pertussis_Homo sapiens_hsa05133 | -0.2203895 |
| 104 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | -0.2167200 |
| 105 | Circadian rhythm_Homo sapiens_hsa04710 | -0.2103428 |
| 106 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | -0.2098462 |
| 107 | Mineral absorption_Homo sapiens_hsa04978 | -0.2077807 |
| 108 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | -0.2065251 |
| 109 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.2041110 |
| 110 | Protein export_Homo sapiens_hsa03060 | -0.1905061 |
| 111 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | -0.1699176 |
| 112 | Pyrimidine metabolism_Homo sapiens_hsa00240 | -0.1676579 |
| 113 | Hepatitis C_Homo sapiens_hsa05160 | -0.1562878 |
| 114 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.1101322 |
| 115 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0948570 |
| 116 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0772088 |
| 117 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.0767583 |
| 118 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0765997 |
| 119 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0723992 |
| 120 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0498026 |
| 121 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0032298 |

